Wariness in Indonesia as Chinese Sinovac Covid-19 jabs start | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Friday
July 25, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
FRIDAY, JULY 25, 2025
Wariness in Indonesia as Chinese Sinovac Covid-19 jabs start

Coronavirus chronicle

Reuters
13 January, 2021, 03:25 pm
Last modified: 13 January, 2021, 03:31 pm

Related News

  • 5 killed after Indonesian ferry catches fire; hundreds rescued
  • Dhaka to seek G2G coal import, investment in solar plants during CA’s visit to Jakarta
  • Indonesia says US trade deal reached after 'extraordinary struggle'
  • Trump sets 19% tariff on Indonesia goods in latest deal, EU readies retaliation
  • Indonesia volcano spews 18-kilometre ash tower: agency

Wariness in Indonesia as Chinese Sinovac Covid-19 jabs start

Nearly 1.5 million health workers are first in line to be immunised in the world's fourth most populous country after it became the first outside China to start mass vaccinations with Chinese company Sinovac Biotech's CoronaVac

Reuters
13 January, 2021, 03:25 pm
Last modified: 13 January, 2021, 03:31 pm
Officers carry Covid-19 vaccine amid the coronavirus disease (COVID-19) pandemic in Banda Aceh, Aceh Province, Indonesia, January 12, 2021. Ampelsa/Antara Foto via REUTERS
Officers carry Covid-19 vaccine amid the coronavirus disease (COVID-19) pandemic in Banda Aceh, Aceh Province, Indonesia, January 12, 2021. Ampelsa/Antara Foto via REUTERS

Indonesian doctors have suffered one of the world's highest death rates from the coronavirus, but that has not stopped some from voicing concerns over the vaccination campaign.

Nearly 1.5 million health workers are first in line to be immunised in the world's fourth most populous country after it became the first outside China to start mass vaccinations with Chinese company Sinovac Biotech's CoronaVac.

"I'm not rejecting vaccines, I'm rejecting Sinovac's," said Yusdeny Lanasakti, an East Java doctor who is worried about the vaccine's efficacy.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

The vaccine was 50.4% effective in a Brazilian trial, researchers said on Tuesday. Indonesia approved it for emergency use based on interim data showing 65.3% efficacy. Turkish researchers provided an interim figure of 91.25%.

Sinovac did not respond immediately to a request for comment.

Bambang Heriyanto, corporate secretary of Bio Farma, the Indonesian company involved in the trials, said the Brazilian data still topped the World Health Organization's benchmark of 50%, however.

The Indonesian Medical Association, which says at least 259 Indonesian doctors died of COVID-19 by Saturday, is also encouraging use of the vaccine in the country of 270 million.

"We could reduce the high number of deaths among doctors and medical workers," said its head, Daeng M. Faqih.

Indonesian doctors' deaths amount to more than a third of India's 736 such fatalities, but India has more than five times as many people, with six times as many virus deaths as the 24,434 recorded in Indonesia from 846,765 infections.

Questions

Dominicus Husada, a pediatrician in East Java, told Reuters he was ready for vaccination but added, "There are a few aspects that have not been answered, like how long immunity lasts and how it lessens over time."

Doctors wanted more information to assuage concerns, said Tri Maharani, another East Java doctor, who has already had COVID-19 and so will not get the vaccine.

Dicky Budiman, an epidemiologist at Australia's Griffith University, added, "If there is doubt among health professionals, this means there are root issues."

These may include a strategy that is not optimal, or information supplied by the government that is not enough for professionals, particularly regarding benefits and risks, he added.

Siti Nadia Tarmizi, a senior health ministry official, said there would be no sanctions for doctors who refused vaccination, but urged medical workers not to be wary.

Most nurses are ready for vaccination, said Harif Fadhillah, who heads the Indonesian Nurses Association.

Scepticism over vaccines is an additional challenge for Indonesia in its plan to inoculate more than 180 million people living across thousands of islands over the next 15 months.

A December poll showed just 37% of Indonesians were willing to be vaccinated while 40% would consider it and 17% refuse.

Sinovac is Indonesia's biggest vaccine supplier, but it has also secured doses from AstraZeneca and some from Pfizer and its partner BioNTech, which has shown efficacy of more than 95%.

To try to spur participation in the campaign, President Joko Widodo got the Sinovac vaccine on Wednesday.

But Agnes Christie Supangkat, a doctor in Jakarta, the capital, said she was not convinced and would not be getting vaccinated.

"It seems it is being rushed to suppress the pandemic, but only a few trials have been done," she said.

Top News

Coronavirus Vaccine / covid-19 vaccine / Coronavac / Sinovac Biotech / Sinovac Covid-19 Vaccine / Chinese Sinovac company / Sinovac vaccine / Indonesia / Vaccine distribution

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • The supporters of local Awami League and Chhatra League locked in a clash with police following attacks on NCP convoy this afternoon (16 July). Photo: Collected
    5 killed in political clash in Gopalganj: ASK demands independent investigation
  • On 21 July, a Bangladesh Air Force (BAF) F-7 BGI training fighter jet crashed into Milestone School and College in Uttara, killing at least 31. Photo: Mehedi Hasan
    Milestone tragedy: Death toll rises to 32 as another child dies
  • File photo of a new NBR office in Agargaon, Dhaka. Photo: UNB
    Clear consignments in a day, customs officials directed

MOST VIEWED

  •  ABM Khairul Haque. File Photo: Collected
    Former chief justice Khairul Haque detained
  • File photo of Bangladesh Bank. Photo: TBS
    Governor Mansur orders withdrawal of BB dress code after directive draws criticism
  • Hasina and Taposh in an event in 2020. Photo: Collected
    Al Jazeera investigation: Hasina, in call with Taposh, talks using helicopter to shoot, crush protesters in July uprising
  • Representational image. File photo: TBS
    Govt okays proposed tariff structure for Chattogram Port, rates to rise by up to 440%
  • Representational image. Photo: Collected
    Tariff talks: Bangladesh, US set for crucial virtual meeting on 29 July
  • Mehreen Ahmed speaking to media on 11 July 2025. Photo: Collected
    Court disposes of Dhaka girl's case against parents seeking 'protection from abuse'

Related News

  • 5 killed after Indonesian ferry catches fire; hundreds rescued
  • Dhaka to seek G2G coal import, investment in solar plants during CA’s visit to Jakarta
  • Indonesia says US trade deal reached after 'extraordinary struggle'
  • Trump sets 19% tariff on Indonesia goods in latest deal, EU readies retaliation
  • Indonesia volcano spews 18-kilometre ash tower: agency

Features

Illustration: TBS

The future of medicine: How innovations will catalyse quantum leaps in healthcare by 2055

16h | The Big Picture
Photo: Collected

24 July: More than 1400 arrested, 3 missing coordinators found

1d | Panorama
Photo: Mehedi Hasan/TBS

Aggrieved nation left with questions as citizens rally to help at burn institute

2d | Panorama
Photo: Mehedi Hasan/TBS

Mourning turns into outrage as Milestone students seek truth and justice

2d | Panorama

More Videos from TBS

All Previous Records Broken in Dinajpur, Rice Prices Are Rising

All Previous Records Broken in Dinajpur, Rice Prices Are Rising

1h | TBS Stories
There are many more examples of trials of Chief Justices in the world.

There are many more examples of trials of Chief Justices in the world.

15h | TBS Today
Why is there a massive conflict between Thailand and Cambodia?

Why is there a massive conflict between Thailand and Cambodia?

15h | TBS News Updates
Former Chief Justice ABM Khairul Haque in prison

Former Chief Justice ABM Khairul Haque in prison

15h | TBS Today
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net